Physician profile
Anthony E Decicco
NPI 1932499886
$3,337.85
in general payments reported to CMS, 2019-2025
26 companies · $32.40 in 2025
The $32.40 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $637 · 2021: $641 · 2022: $249 · 2023: $783 · 2024: $762 · 2025: $32.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $688.16 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $578.17 | 2019-2025 | Avvigo Guidance System, Watchman Flx, General - Ep |
| Medtronic, INC. | $542.11 | 2021-2023 | Euphora |
| Abiomed | $416.48 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $162.11 | 2022-2023 | |
| Amgen INC. | $115.11 | 2020-2022 | |
| Medtronic Vascular, INC. | $114.96 | 2020 | |
| Abbott Laboratories | $104.71 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $67.27 | 2019-2021 | |
| Pfizer INC. | $66.21 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $64.29 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $62.29 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.62 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $48.62 | 2024 | Arcalyst |
| United Therapeutics Corporation | $35.40 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Venclose INC. | $31.19 | 2020 | |
| Terumo Medical Corporation | $30.93 | 2023 | Angio-Seal, Tr Band |
| E.R. Squibb & Sons, L.L.C. | $30.46 | 2021-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $19.64 | 2021 | |
| Stryker Corporation | $18.03 | 2024 | Synchro Select |
| Astellas Pharma US INC | $16.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.89 | 2020 | |
| Merck Sharp & Dohme LLC | $14.48 | 2022 | |
| Braemar Manufacturing, LLC | $13.59 | 2019 | |
| Amarin Pharma, INC. | $13.41 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Decicco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.